CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,914,702
+$5,921,668 QoQ
Shares Held
616,310
+12.7% QoQ
Ownership
0.722%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. GLUE ranks #88 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,914,702 | 616,310 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,993,034 | 546,689 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,035,835 | 448,714 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,840,015 | 383,268 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,719,829 | 381,337 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,677,522 | 361,535 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,571,075 | 370,472 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,836,439 | 346,498 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,166,132 | 311,800 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,766,603 | 250,582 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,387,425 | 245,562 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,161,541 | 242,493 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,576,993 | 230,218 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,747,966 | 224,386 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,708,323 | 224,484 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,741,966 | 213,215 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,123,982 | 116,234 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,758,108 | 125,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,736,966 | 85,062 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,781,820 | 79,974 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||